U.S. Paper and Forestry Products Stock News

Southwest Gas Holdings (SWX) packed several updates into its latest announcement, including full year 2025 earnings, fresh 2026 earnings guidance, a higher quarterly dividend, and a planned CEO transition welcomed by the board. See our latest analysis for Southwest Gas Holdings. The stock has pulled back slightly in the latest session with a 1 day share price return decline of 2.11%. However, a 30 day share price return of 5.75% and a 90 day share price return of 10.91% suggest positive...

In February 2026, Assured Guaranty Ltd. reported past fourth-quarter 2025 revenue of US$277 million and net income of US$119 million, alongside full-year 2025 revenue of US$1.11 billion and net income of US$503 million, while also raising its quarterly dividend to US$0.38 per share. Beyond these headline figures, the company further reshaped its profile by acquiring Warwick Re Limited to enter life and annuity reinsurance, extending a 14-year streak of dividend growth and shrinking its...

Genesis Energy, NYSE:GEL, has launched a cash tender offer to repurchase its 7.750% senior notes due 2028. The offer targets a portion of the outstanding notes and is intended to adjust the company’s existing debt profile. This move focuses on the 2028 maturity, which is a key part of Genesis Energy’s longer term capital structure. For equity holders, the timing is notable. Genesis Energy’s share price is $18.49, with returns of 3.6% over the past week and 7.6% over the past month. Over...

Dyne Therapeutics (NasdaqGS:DYN) is preparing a U.S. Accelerated Approval submission for z-rostudirsen in Duchenne muscular dystrophy. The company is also gearing up for a Phase 3 trial of z-basivarsen in myotonic dystrophy. Dyne is scaling its operations and expanding its development pipeline to support potential commercialization. Dyne Therapeutics focuses on neuromuscular disease therapies, an area where treatment options remain limited and unmet medical need is high. As z-rostudirsen...

BridgeBio Pharma recently announced that interim analysis from its ongoing Phase 3 FORTIFY trial of BBP-418 in limb-girdle muscular dystrophy type 2I/R9 met efficacy endpoints, and that expanded data will be shared in a late-breaking oral session and multiple presentations at the March 2026 MDA Clinical and Scientific Conference. This concentrated spotlight on BBP-418, spanning efficacy data, assay development, real-world burden, and health economics, underscores how BridgeBio is building a...

Why Solaris Energy Infrastructure is back on investor radar Solaris Energy Infrastructure (SEI) has drawn fresh attention after reporting fourth quarter and full year 2025 results, alongside approving its 30th consecutive quarterly dividend of $0.12 per share for first quarter 2026. The update combined higher reported sales and revenue with a quarterly net loss. The dividend decision highlighted the board’s ongoing approach to shareholder cash returns, giving investors new information on both...

ASGN (ASGN) has drawn investor attention after recent share price moves, with the stock up 2.8% over the past day but showing weaker performance over the past month and the past 3 months. See our latest analysis for ASGN. That 2.8% 1 day share price gain comes after a tougher stretch, with a 30 day share price return of 15.1% decline and a 1 year total shareholder return of 37% decline. This suggests recent momentum has been fading as investors reassess growth expectations and risk. If ASGN’s...

If you are wondering whether Broadridge Financial Solutions is reasonably priced or offering value right now, you will want to see how its current share price stacks up against a few different valuation yardsticks. The stock last closed at US$190.89, with returns of 4.2% over the past week and 2.7% over the past month, set against a year to date return of 13.4% decline and a 1 year return of 18.5% decline, while the 3 year and 5 year returns sit at 42.2% and 43.6% respectively. Recent news...

TriMas Corporation recently reported past fourth-quarter and full-year 2025 results showing higher sales and much stronger net income and earnings per share, while also completing a large share repurchase program and updating its authorization. The company’s new 2026 sales growth guidance for its Packaging and Specialty Products businesses, alongside meaningful buybacks, highlights management’s confidence in the core operations and capital return approach. We’ll now examine how TriMas’...

Targa Resources recently completed a US$1.50 billion senior unsecured notes offering, issuing US$750.00 million of 4.35% notes due 2031 and US$750.00 million of 6.05% notes due 2056, with the proceeds earmarked for refinancing debt, repaying commercial paper, and funding capital needs. This new long-dated funding, alongside record 2025 adjusted EBITDA and a sizeable 2026 capital program, reflects management’s focus on maintaining financial flexibility while backing its buildout of Permian...

CECO Environmental Corp. recently reported past fourth-quarter 2025 sales of US$214.69 million and full-year 2025 sales of US$774.38 million, then raised its 2026 revenue guidance to a range of US$925 million to US$975 million following this strong performance. While full-year net income rose to US$50.05 million, the quarter saw lower earnings despite higher sales, highlighting the company’s ongoing balance between growth investments and near-term profitability. We’ll now examine how CECO’s...

Agnico Eagle Mines (NYSE:AEM) reported record gold production for Q4 2025. The company exceeded earnings expectations for the quarter and announced a 12.5% dividend increase. A multi year plan targets a 20% to 30% increase in production, aiming to lift both scale and cash returns to shareholders. For investors, NYSE:AEM comes into this news with a share price of $221.49 and very large 3 year and multi year returns, including a 128.6% gain over the past year and 29.9% year to date. That...

Constellation Energy (CEG) is back in focus after reporting fourth quarter and full year 2025 results that topped analyst expectations, closing its Calpine acquisition and securing new long term power deals with major data center operators. See our latest analysis for Constellation Energy. That earnings beat, the Calpine closing and fresh data center contracts have come alongside a 23.7% 1 month share price return and a 60.78% 1 year total shareholder return. However, the year to date share...

If you are wondering whether Grupo Aeroméxico. de is starting to look mispriced, this article will walk through what the current share price might be implying about the stock. The shares last closed at US$16.60, with returns of a 16.5% decline over 7 days, a 17.6% decline over 30 days and a 24.4% decline year to date. These moves may have changed how the market is thinking about its risk and return profile. Recent coverage around Grupo Aeroméxico. de has focused on how the company is...

Fluence Energy (FLNC) moved back into focus after Jefferies upgraded the stock, pointing to robust U.S. market conditions, a record project backlog, and reaffirmed revenue targets supported by substantial new orders. See our latest analysis for Fluence Energy. Jefferies’ upgrade lands after a sharp reset in sentiment, with a 51.10% 30 day share price return decline and a 31.51% year to date share price return decline. At the same time, the 1 year total shareholder return is 198.48% and the 3...

Recent Share Performance and Business Snapshot Full Truck Alliance (YMM) has drawn fresh attention after a period of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months. At a last close of US$8.94, the company sits against a backdrop of reported revenue of CN¥12,471.511 and net income of CN¥3,978.797, alongside annual revenue and net income growth figures. See our latest analysis for Full Truck Alliance. The recent 1 day share price...

Zai Lab Limited recently reported past fourth-quarter 2025 results, with revenue rising to US$127.6 million from US$109.07 million and net loss narrowing to US$50.41 million from US$81.68 million a year earlier. The reduced basic loss per share from continuing operations, improving to US$0.50 from US$0.80, highlights meaningful progress in containing costs alongside revenue growth. Next, we will examine how Zai Lab’s improved revenue and narrower loss shape the existing investment narrative...

In late February 2026, IBM announced a collaboration to embed Deepgram’s voice AI into watsonx Orchestrate and secured a US$112.00 million, up-to-five-year Defense Commissary Agency contract to upgrade and maintain electronic shelf labels across 235 commissaries worldwide. Taken together with the recent expansion of IBM’s board to fourteen directors, these moves highlight how the company is deepening its focus on enterprise-grade AI, automation, and mission-critical government...

Strategic Education (STRA) is back in focus after reporting fourth quarter and full year 2025 results that highlighted higher revenue, stronger margins, and record contributions from several high margin units supported by AI driven cost savings. See our latest analysis for Strategic Education. The recent results, fresh quarterly dividend of $0.60 per share, ongoing buybacks, and insider selling activity sit against a share price of $84.16, with a 7.10% year to date share price return and a 5...

If you are looking at Western Midstream Partners and wondering whether the current price reflects its true worth, this article will walk you through the key signals that matter. The units last closed at US$42.19, with returns of 2.5% over the past week, 4.7% over the past month, 6.2% year to date and 22.3% over the last year, plus very large gains over 3 and 5 years that may have changed how investors view its risk and reward profile. Recent news coverage has focused on Western Midstream...

If you are trying to figure out whether Stride's current share price really reflects its underlying worth, you are in the right place. Stride's share price recently closed at US$86.32, with returns of 0.5% over 7 days, 0.6% over 30 days, 33.6% year to date, a 35.2% decline over 1 year, and 100.2% and 218.8% over 3 and 5 years respectively. These figures may have investors reassessing both its growth potential and risk profile. Recent headlines around Stride have focused on its role in...

Event overview and why Pattern Group is on investors’ radar Pattern Group (PTRN) recently completed its rebrand from Covalent Group, Inc. to Pattern Group Inc., a shift that puts fresh attention on how its ecommerce acceleration model and AI driven tools might influence the stock’s appeal. See our latest analysis for Pattern Group. Pattern Group’s recent rebrand arrives after a mixed run for the shares. A 7 day share price return of 10.54% contrasts with a 90 day share price return decline of...

Why Viking Therapeutics is on investors’ radar today Viking Therapeutics (VKTX) has drawn attention after recent trading left the stock with a past 3 months total return of 186.45% and a one year total return of 9.87%. See our latest analysis for Viking Therapeutics. The recent pullback, with a 7 day share price return of a 4.43% decline and a 90 day share price return of an 18.26% decline to US$31.51, sits against a much stronger 3 year total shareholder return of 186.45%. This suggests that...

Cardinal Health (CAH) is back in focus after recent share price moves, with the stock closing at $216.02. For investors, the key question is how this current level aligns with the company’s fundamentals. See our latest analysis for Cardinal Health. The recent 1 day share price return of 3.21% decline and 7 day share price return of 4.89% decline come after a steadier period, with a 90 day share price return of 8.65% and a 1 year total shareholder return of 72.21%. This suggests longer term...